Clinical implications of the hemodynamic effects of beta blockade.

[1]  J. Cohn,et al.  Relative attenuation of sympathetic drive during exercise in patients with congestive heart failure. , 1985, Journal of the American College of Cardiology.

[2]  J. Cohn,et al.  Learned precise cardiovascular control through graded central sympathetic stimulation. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[3]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[4]  R. Erbel,et al.  Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. , 1984, Circulation.

[5]  L. Hansson,et al.  Mode of action of beta-adrenoceptor blocking agents in hypertension. A comparison between metoprolol and pindolol with special reference to peripheral vascular effects. , 2009, Acta medica Scandinavica. Supplementum.

[6]  B. Clark.  Beta-adrenoceptor-blocking agents: are pharmacologic differences relevant? , 1982, American heart journal.

[7]  J. Cohn,et al.  Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. , 1982, The American journal of cardiology.

[8]  J. Cohn,et al.  A review of the haemodynamic effects of labetalol in man. , 1982, British journal of clinical pharmacology.

[9]  J. Cohn,et al.  Short‐Term Systemic Hemodynamic Adaptation to Beta‐Adrenergic Inhibition with Atenolol in Hypertensive Patients , 1981, Hypertension.

[10]  S. Z. Langer.  Presynaptic regulation of the release of catecholamines. , 1980, Pharmacological reviews.

[11]  K. Swedberg,et al.  Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. , 1980, British heart journal.

[12]  J. Laragh,et al.  Contrasting effects of acute beta blockade with propranolol on plasma catecholamines and renin in essential hypertension: a possible basis for the delayed antihypertensive response. , 1979, American heart journal.

[13]  T. Philipp,et al.  Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension. , 1978, The American journal of medicine.

[14]  J. Cohn,et al.  Hemodynamic Effects of Labetalol, an Alpha and Beta Adrenergic Blocking Agent, in Hypertensive Subjects , 1977, Circulation.

[15]  P. Lewis.  The essential action of propranolol in hypertension. , 1976, The American journal of medicine.

[16]  E. Varnauskas,et al.  Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. , 1975, British heart journal.

[17]  P. Lund-johansen.  Hemodynamic changes at rest and during exercise in long-term clonidine therapy of essential hypertension. , 2009, Acta medica Scandinavica.

[18]  G. Berglund,et al.  A within-patient comparison of alprenolol and propranolol in hypertension. , 2009, Acta medica Scandinavica.

[19]  A. Axford,et al.  Propranolol in the Treatment of Hypertension , 1971, The British journal of clinical practice.

[20]  H. Granger,et al.  Whole‐Body Circulatory Autoregulation and Hypertension , 1971, Circulation research.

[21]  E. Frohlich,et al.  Re‐Examination of the Hemodynamics of Hypertension , 1969, The American journal of the medical sciences.

[22]  P. Gillam,et al.  Propranolol in hypertension. , 1966, The American journal of cardiology.

[23]  S. Stephen.  Unwanted effects of propranolol. , 1966, The American journal of cardiology.

[24]  E. Braunwald,et al.  Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. , 1962, The New England journal of medicine.